Neuromuscular Disorders
Volume 18, Issue 7 , Pages 583-592 , July 2008

156th ENMC International Workshop: Desmin and protein aggregate myopathies, 9–11 November 2007, Naarden, The Netherlands

Received 4 April 2008

References 

  1. Goebel HH, Fardeau M. Desmin in myology, 24th European Neuromuscular Center (ENMC)-Sponsored International Workshop, 5–7 November 1993, Naarden, The Netherlands. Neuromuscul Disord. 1995;5:161–166
  2. Goebel HH, Fardeau M. Familial desmin-related myopathies and cardiomyopathies – from myopathology to molecular and clinical genetics, 36th European Neuromuscular Centre (ENMC)-sponsored International Workshop, 20–22 October 1995, Naarden, The Netherlands. Neuromuscul Disord. 1996;6:383–388
  3. Goebel HH, Fardeau M. Desmin – protein surplus myopathies, 96th European Neuromuscular Centre (ENMC)-sponsored International Workshop, 14–16 September 2001, Naarden, The Netherlands. Neuromuscul Disord. 2002;12:687–692
  4. Goebel HH, Fardeau M. 121st ENMC International Workshop on Desmin and Protein Aggegate Myopathies, 7–9 November 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14:767–773
  5. Fardeau M, Godet-Guillain J, Tomé FSM, et al. Une nouvelle affection musculaire familiale, définie par l’accumulation intra-sarco-plasmique d’un matériel granulo-filamentaire dense en microscopie électronique. Rev Neurol (Paris). 1978;134:411–425
  6. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature. 1980;283:249–256
  7. Rappaport L, Contard F, Samuel JL, et al. Storage of phosphorylated desmin in a familial myopathy. FEBS Lett. 1988;231:421–425
  8. Vicart P, Caron A, Guicheney P, et al. A missense mutation in the alpha-B crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998;20:92–95
  9. Berry V, Francis P, Reddy MA, et al. Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans. Am J Hum Genet. 2001;69:1141–1145
  10. Selcen D, Engel AG. Myofibrillar myopathy caused by novel dominant negative αB-crystallin mutations. Ann Neurol. 2003;54:804–810
  11. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain. 2004;127:439–451
  12. Selcen D, Engel AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol. 2005;57:269–276
  13. Carlsson L, Li ZL, Paulin D, et al. Differences in the distribution of synemin, paranemin, and plectin in skeletal muscles of wild-type and desmin knock-out mice. Histochem Cell Biol. 2000;114:39–47
  14. Titeux M, Brocheriou V, Xue Z, et al. Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. Eur J Biochem. 2001;268:6435–6449
  15. McCullagh KJ, Edwards B, Poon E, Lovering RM, Paulin D, Davies KE. Intermediate filament-like protein syncoilin in normal and myopathic striated muscle. Neuromuscul Disord. 2007;17:970–979
  16. Xue ZG, Cheraud Y, Brocheriou V, et al. The mouse synemin gene encodes three intermediate filament proteins generated by alternative exon usage and different open reading frames. Exp Cell Res. 2004;298:431–444
  17. Izmiryan A, Cheraud Y, Khanamiryan L, et al. Different expression of synemin isoforms in glia and neurons during nervous system development. Glia. 2006;54:204–213
  18. Sun N, Critchley DR, Paulin D, Li Z, Robson RM. Human alpha-synemin interacts directly with vinculin and metavinculin. Biochem J. 2008;409:657–667
  19. Olive M, Goldfarb L, Dagvadorj A, et al. Expression of the intermediate filament protein synemin in myofibrillar myopathies and other muscle diseases. Acta Neuropathol (Berl). 2003;106:1–7
  20. Howman EV, Sullivan N, Poon EP, Britton JE, Hilton-Jones D, Davies KE. Syncoilin accumulation in two patients with desmin-related myopathy. Neuromuscul Disord. 2003;13:42–48
  21. Lapouge K, Fontao L, Champliaud MF. New insights into the molecular basis of desmoplakin- and desmin-related cardiomyopathies. J Cell Sci. 2006;119:4974–4985
  22. Balogh J, Li Z, Paulin D, Arner A. Desmin filaments influence myofilament spacing and lateral compliance of slow skeletal muscle fibers. Biophys J. 2005;88:1156–1165
  23. Bär H, Mucke N, Kostareva A, Sjöberg G, Aebi U, Herrmann H. Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proc Natl Acad Sci USA. 2005;102:15099–15104
  24. Olive M, Goldfarb LG, Shatunov A, Fischer D, Ferrer I. Myotilinopathy: refining the clinical and myopathological phenotype. Brain. 2005;128:2315–2326
  25. Bär H, Fischer D, Goudeau B, et al. Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum Mol Genet. 2005;14:1251–1260
  26. Walter MC, Reilich P, Huebner A. Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain. 2007;130:1485–1496
  27. Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology. 2004;62:1363–1371
  28. Simon S, Fontaine JM, Martin JL, et al. Myopathy-associated alphaB-crystallin mutants: abnormal phosphorylation, intracellular location, and interactions with other small heat shock proteins. J Biol Chem. 2007;282:34276–34287
  29. Otey CA, Rachlin A, Moza M, Arneman D, Carpen O. The palladin/myotilin/myopalladin family of actin-associated scaffolds. Int Rev Cytol. 2005;246:31–58
  30. Salmikangas P, van der Ven PF, Lalowski M, et al. Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly. Hum Mol Genet. 2003;12:189–203
  31. Moza M, Mologni L, Trokovic R, Faulkner G, Partanen J, Carpen O. Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice. Mol Cell Biol. 2007;27:244–252
  32. Garvey SM, Miller SE, Claflin DR, Faulkner JA, Hauser MA. Transgenic mice expressing the myotilin T57I mutation unite the pathology associated with LGMD1A and MFM. Hum Mol Genet. 2006;15:2348–2362
  33. Sewry CA, Muller C, Davis M, et al. The spectrum of pathology in central core disease. Neuromuscul Disord. 2002;12:930–938
  34. Bönnemann C, Thompson TG, van der Ven PFM, et al. Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle. J Neurol Sci. 2003;206:71–78
  35. Kley RA, Hellenbroich Y, van der Ven PF, et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain. 2007;130:3250–3264
  36. Vorgerd M, van der Ven PFM, Bruchertseifer V, et al. A mutation in the dimerization domain of filamin C causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet. 2005;77:297–304
  37. Hübbers CU, Clemen CS, Kesper K, et al. Pathological consequences of VCP mutations on human striated muscle. Brain. 2007;130:381–393
  38. Schröder R, Watts GDJ, Mehta SG, et al. Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol. 2005;57:457–461
  39. Janue A, Olive M, Ferrer I. Oxidative stress in desminopathies and myotilinopathies: a link between oxidative damage and abnormal protein aggregation. Brain Pathol. 2007;17:377–388
  40. Janue A, Odena MA, Oliveira E, Olive M, Ferrer I. Desmin is oxidized and nitrated in affected muscles in myotilinopathies and desminopathies. J Neuropathol Exp Neurol. 2007;66:711–723
  41. Barrachina M, Moreno J, Juves S, Moreno D, Olive M, Ferrer I. Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy. Am J Pathol. 2007;171:1312–1323
  42. Schoser BG. Autophagic changes in skeletal muscle – towards the enigma of rimmed and round vacuoles. Clin Neuropathol; in press.

PII: S0960-8966(08)00108-9

doi: 10.1016/j.nmd.2008.04.008

Neuromuscular Disorders
Volume 18, Issue 7 , Pages 583-592 , July 2008

Article Tools